Compared with established molecular markers used in glioma molecular subtyping, such as IDH mutation, 1p/19q deletion, and MGMT methylation status, the open chromatin feature-based methods could capture the characteristics of glioma in a dynamic way. This evidence concerns the gene MGMT and central nervous system cancer.